e-SPACE Cardio-Renal-Metabolic 2022: On-demand

Published: 11 April 2022

  • Views:

    Views Icon 19568
  • Likes:

    Heart Icon 7
  • episode_image
    1m 29s
    Part 4 | Session 1 Introduction Vijay Chopra, Marco Metra
  • episode_image
    1m 9s
    Part 6 | Session 1 Introduction Andrew JS Coats, Alice Cheng
Average (ratings)
No ratings
Your rating

Overview

e-SPACE CARDIO-RENAL-METABOLIC 2022, held on 4-6 March 2022, was the second edition of the global online conference on cardio renal metabolic diseases.

 

The organisers, under the direction of a world-renowned scientific committee, brought together leading experts in cardiology, nephrology, and diabetology to share clinical practice strategies in treating the inter-related diseases now affecting hundreds of millions people worldwide.

 

This on-demand version of the event comprises:

 

  • Presentations and discussions with leading experts
  • Evidence-based management strategies for diabetes, cardiovascular disease, heart failure, kidney disease & obesity
  • Insight to SLGT2i, GLP-1RA and other emerging therapies
  • 'Meet the Expert' sessions

 

e-SPACE Cardio-Renal-Metabolic 2022 was supported by the following companies:

More from this programme

Part 1

Meet the Expert: IgA nephropathy: current optimal management

Part 3

Industry Session: Iron deficiency in heart failure and kidney disease: interdisciplinary crosstalk

Part 5

Meet the Experts: NAFLD/NASH as a metabolic disease: improving patients outcomes

Part 7

Meet the Experts: The meaning of Hemoglobin A1C for the nephrologist and the cardiologist

Part 12

Meet the Experts: CV, mortality & kidney outcomes with GLP-1 AR in patients with T2DM

Part 14

Meet the Experts: The HF Diabetic patient with CKD: optimizing care for a high-risk group

Part 17

Meet the Expert: HIF PHI: What do we know and don't know in 2022

Part 19

Industry Session: SGLT2 inhibition in the comorbid CKD patient

Satellite Symposium supported by an unrestricted educational grant from AstraZeneca

Part 21

Meet the Expert: SGLT2 inhibitors in heart failure: Improving outcomes across the spectrum of the disease

Part 23

Meet the Expert: The meaning of eGFR for the cardiologists and diabetologist

Part 25

Meet the Experts: Personalized care of patients with heart failure: hyperkalemia as a barrier to optimal medical therapy

Part 26

Meet the Expert: SGLT2, the statin of the 21st century

Part 28

Meet the Experts: Reducing the risk of cardiovascular events for patients with CKD and T2DM: new treatment options

Part 31

Meet the Expert: Management of worsening HF

Part 32

Session 16: Harmonising the gluco-and cardio-centric management of diabetes

Faculty Biographies